Target-dependent on/off switch increases ribozyme fidelity

Nucleic Acids Research

Volumn 33, Issue 4, 2005, Pages 1240-1248

  Bergeron, Lucien Junior ^a   Perreault, Jean Pierre ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOZYME; VIRUS RNA; RNA;

ARTICLE; BIOSENSOR; CONTROLLED STUDY; FUNCTIONAL GENOMICS; GENE SWITCHING; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RNA CLEAVAGE; RNA TRANSCRIPTION; CATALYSIS; CELL LINE; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; HEPATITIS VIRUS; METABOLISM;

HEPATITIS DELTA VIRUS;

CATALYSIS; CELL LINE; GENETIC ENGINEERING; HEPATITIS VIRUSES; HUMANS; RNA; RNA, CATALYTIC; RNA, VIRAL; SUBSTRATE SPECIFICITY;

EID: 14844365734     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gki278     Document Type: Article

References (30)

1. Lewin,A.S. and Hauswirth,W.W. (2001) Ribozyme gene therapy: Applications for molecular medicine. Trends Mol. Med., 7, 221-228.
2. Michienzi,A. and Rossi,J.J. (2001) Intracellular applications of ribozymes. Methods Enzymol., 341, 581-596.
3. Pebernard,S. and Iggo,R.D. (2004) Determinants of interferon-stimulated gene induction by RNAi vectors. Differentiation, 72, 103-111.
4. Carlson,C.B., Stephens,O.M. and Beal,P.A. (2003) Recognition of double-stranded RNA by proteins and small molecules. Biopolymers, 70, 86-102.
5. Sledz,C.A., Holko,M., de Veer,M.J., Silverman,R.H. and Williams,B.R. (2003) Activation of the interferon system by short-interfering RNAs. Nature Cell Biol., 5, 834-839.
6. Breaker,R.R. (2002) Engineered allosteric ribozymes as biosensor components. Curr. Opin. Biotechnol., 13, 31-39.
7. Burke,D.H., Ozerova,N.D.S. and Nilsen-Hamilton,M. (2002) Allosteric hammerhead ribozyme TRAPS. Biochemistry, 41, 6588-6594.
8. Wang,D.Y. and Sen,D. (2002) Rationally designed allosteric variants of hammerhead ribozymes responsive to the HIV-1 Tat protein. Comb. Chem. High Throughput Screen, 5, 301-312.
9. Wang,D.Y., Lai,B.H.Y., Feldman,A.R. and Sen,D. (2002) A general approach for the use of oligonucleotide effectors to regulate the catalysis of RNA-cleaving ribozymes and DNAzymes. Nucleic Acids Res., 30, 1735-1742.
10. Robertson,M.P. and Ellington,A.D. (1999) In vitro selection of an allosteric ribozyme that transducer analytes to amplicons. Nat. Biotechnol., 17, 62-66.
11. Soukup,G.A. and Breaker,R.R. (1999) Engineering precision RNA molecular switches. Proc. Natl Acad. Sci. USA, 96, 3584-3589.
12. Kuwabara,T., Warashina,M., Tanabe,T., Tani,K., Asano,S. and Taira,K. (1998) A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo. Mol. Cell 2, 617-627.
13. Tang,J. and Breaker,R.R. (1997) Rational design of allosteric ribozymes. Chem. Biol., 4, 453-459.
14. Bergeron,L.J., Ouellet,J. and Perreault,J.P. (2003) Ribozyme-based gene-inactivation systems require a fine comprehension of their substrate specificities; the case of delta ribozyme. Curr. Med. Chem. 10, 2589-2597.
15. Shih,I.H. and Been,M.D. (2002) Catalytic strategies of the hepatitis delta virus ribozymes. Annu. Rev. Biochem., 71, 887-917.
16. Nishikawa,F., Roy,M., Fauzi,H. and Nishikawa,S. (1999) Detailed analysis of stem I and its 5′ and 3′ neighbor regions in the trans acting HDV ribozyme. Nucleic Acids Res., 27, 403-410.
17. Nassal,M. (1992) The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J. Virol. 6, 4107-4116.
18. Alaoui-Ismaili,M.H., Gervais,C., Brunette,S., Gouin,G., Hamel,M., Rando,R.F. and Bedard,J. (2000) A novel high throughput screening assay for HCV NS3 helicase activity. Antiviral Res., 46, 181-193.
19. Bergeron,L.J. and Perreault,J.P. (2002) Development and comparison of procedures for the selection of delta ribozyme cleavage sites within the hepatitis B virus. Nucleic Acids Res., 30, 4682-4691.
20. D'Anjou,F., Bergeron,L.J., Larbi,N.B., Fournier,I., Salzet,M., Perreault,J.P. and Day,R. (2004) Silencing of SPC2 expression using an engineered δ ribozyme in the mouse (3TC-3 endocrine cell line. J. Biol. Chem., 279, 14232-14239.
21. Lévesque,D., Choufani,S. and Perreault,J.P. (2002) Delta ribozyme benefits from a good stability in vitro that becomes outstanding in vivo. RNA, 8, 464-477.
22. Roy,G., Ananvoranich,S. and Perreault,J.P. (1999) Delta ribozyme has the ability to cleave in trans an mRNA. Nucleic Acids Res., 27, 942-948.
23. Fersht,A. (1999) Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding. W.H. Freeman and Company, New York, NY, Chapters 3, 10 and 13.
24. Jankowsky,E. and Schwenzer,B. (1996) Oligonucleotide facilitators may inhibit or activate a hammerhead ribozyme. Nucleic Acids Res., 24, 423-429.
25. Jankowsky,E. and Schwenzer,B. (1996) Efficient improvement of hammerhead ribozyme mediated cleavage of long substrates by oligonucleotide facilitators. Biochemistry, 35, 15313-15321.
26. Odreman-Macchioli,F., Baralle,F.E. and Buratti,E. (2001) Mutational analysis of the different bulge regions of hepatitis C virus domain II and their influence on internal ribosome entry site translational ability. J. Biol. Chem., 276, 41648-41655.
27. Kieft,J.S., Zhou,K., Jubin,R., Murray,M.G., Lau,J.Y. and Doudna,J.A. (1999) The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold. J. Mol. Biol., 292, 513-529.
28. Janeway,C.A. and Travers,P. (1997) Immunobiologie. DeBoeck Université, Paris, France, Chapter 7.
29. Deschênes,P., Lafontaine,D.A., Charland,S. and Perreault,J.P. (2000) Nucleotides -1 to -4 of hepatitis delta ribozyme substrate increase the specificity of ribozyme cleavage. Antisense Nucleic Acid Drug Dev. 10, 53-61.
30. Perrotta,A.T. and Been,M.D. (1991) A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature, 350, 434-436.